A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma (Q33504596)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

title

A phase II study of DaunoXome in advanced urothelial transitional cell carcinoma (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

main subject

transitional cell carcinoma

1 reference

based on heuristic

inferred from title

author

Sophie D. Fosså

series ordinal

1

object named as

Fosså SD

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

author name string

Aass N

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

Parö G

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

publication date

1 June 1998

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

published in

European Journal of Cancer

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

volume

34

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

issue

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

page(s)

1131-1132

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

cites work

Chemotherapy for urothelial tract malignancies: breaking the deadlock

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910156-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910156-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomal daunorubicin treatment of HIV-associated Kaposi's sarcoma

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910156-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Liposomal doxorubicin: antitumor activity and unique toxicities during two complementary phase I studies.

1 reference

stated in

Crossref

reference URL

https://api.crossref.org/works/10.1016%2FS0959-8049%2897%2910156-3

retrieved

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

DOI

10.1016/S0959-8049(97)10156-3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

PubMed publication ID

9849467

1 reference

stated in

Europe PubMed Central

PubMed publication ID

9849467

retrieved

27 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33504596&oldid=1535771241"